MADRIGAL PHARMACEUTICALS, INC. (MDGL) › Net IncomeMADRIGAL PHARMACEUTICALS, INC. (MDGL) — Net IncomeAnnual figures by fiscal year, from SEC filings.2016: -$26.39M2017: -$31.15M2018: -$32.81M2019: -$83.95M2020: -$202.24M2021: -$241.85M2022: -$295.35M2023: -$373.63M2024: -$465.89M2025: -$288.28M-$288.28M2016Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$288.28M+38.1%2024-$465.89M-24.7%2023-$373.63M-26.5%2022-$295.35M-22.1%2021-$241.85M-19.6%2020-$202.24M-140.9%2019-$83.95M-155.9%2018-$32.81M-5.3%2017-$31.15M-18.1%2016-$26.39M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share